TILRAY BRA. CL.2 DL-,0001
TILRAY BRA. CL.2 DL-,0001/ US88688T1007 /
TLRY
|
1/8/2025 9:59:36 PM
|
Chg.
-0.07
|
Volume |
Bid10:00:28 PM |
Ask10:00:28 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
1.34EUR
|
-5.20%
|
299,887
Turnover: 411,806.30 |
1.33Bid Size: 3,500 |
1.35Ask Size: 3,500 |
1.2 bill.EUR |
- |
- |
Business description
Tilray Brands, Inc. is a leading global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America.
Management board & Supervisory board
| CEO |
| Irwin D. Simon, |
| Management board |
| Carl Merton, Denise Faltischek, Lloyd Brathwaite, Berrin Noorata, Jared Simon, Mitchell Gendel, Blair MacNeil, Bryan Nolt, Roger Savell, Nyree Pinto, Beer Ty H. Gilmore |
| Supervisory board |
| Irwin D. Simon, Renah Persofsky, ICD.D, Jodi Butts, David Clanachan, John M. Herhalt, Tom Looney, David Hopkinson |
Company data
| Name: |
Tilray Inc. |
| Address: |
265 Talbot Street West,Leamington, ON, N8H 5L4, CAN |
| Phone: |
- |
| Fax: |
- |
| E-mail: |
-
|
| Internet: |
www.tilray.com |
| Industry: |
Healthcare |
| Sector: |
Medical Products |
| Sub sector: |
Medical Supplies |
| End of financial year: |
5/31 |
| Free Float: |
- |
| IPO date: |
7/1/2018 |
Investor relations
| Name: |
- |
| IR phone: |
844-845-7291 |
| IR Fax: |
- |
| IR e-mail: |
-
|
Company calendar
|
CW 2 | 1/9/2025
Interim Report 2nd Quarter/6 Months
|